271 related articles for article (PubMed ID: 25622820)
1. Deeper insight into chronic kidney disease-related atherosclerosis: comparative proteomic studies of blood plasma using 2DE and mass spectrometry.
Luczak M; Formanowicz D; Marczak Ł; Pawliczak E; Wanic-Kossowska M; Figlerowicz M; Stobiecki M
J Transl Med; 2015 Jan; 13():20. PubMed ID: 25622820
[TBL] [Abstract][Full Text] [Related]
2. Label-Free Quantitative Proteomics Reveals Differences in Molecular Mechanism of Atherosclerosis Related and Non-Related to Chronic Kidney Disease.
Luczak M; Suszynska-Zajczyk J; Marczak L; Formanowicz D; Pawliczak E; Wanic-Kossowska M; Stobiecki M
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27144566
[TBL] [Abstract][Full Text] [Related]
3. iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis.
Luczak M; Formanowicz D; Marczak Ł; Suszyńska-Zajczyk J; Pawliczak E; Wanic-Kossowska M; Stobiecki M
Sci Rep; 2016 Sep; 6():32511. PubMed ID: 27600335
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease-related atherosclerosis - proteomic studies of blood plasma.
Luczak M; Formanowicz D; Pawliczak E; Wanic-Kossowska M; Wykretowicz A; Figlerowicz M
Proteome Sci; 2011 May; 9():25. PubMed ID: 21569504
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Profiling of Leukocytes Reveals Dysregulation of Adhesion and Integrin Proteins in Chronic Kidney Disease-Related Atherosclerosis.
Tracz J; Handschuh L; Lalowski M; Marczak Ł; Kostka-Jeziorny K; Perek B; Wanic-Kossowska M; Podkowińska A; Tykarski A; Formanowicz D; Luczak M
J Proteome Res; 2021 Jun; 20(6):3053-3067. PubMed ID: 33939431
[TBL] [Abstract][Full Text] [Related]
6. New insights in molecular mechanisms involved in chronic kidney disease using high-resolution plasma proteome analysis.
Glorieux G; Mullen W; Duranton F; Filip S; Gayrard N; Husi H; Schepers E; Neirynck N; Schanstra JP; Jankowski J; Mischak H; Argilés À; Vanholder R; Vlahou A; Klein J
Nephrol Dial Transplant; 2015 Nov; 30(11):1842-52. PubMed ID: 26160894
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
8. Proteomics analysis of blood plasma in HIV-infected patients with chronic kidney disease.
Lavinya AA; Lee CS; Hashim OH; Azwa I; Rajasuriar R; Lim SK; Wong YF
Clin Biochem; 2019 Nov; 73():90-97. PubMed ID: 31401122
[TBL] [Abstract][Full Text] [Related]
9. Applying Proteomics and Integrative "Omics" Strategies to Decipher the Chronic Kidney Disease-Related Atherosclerosis.
Tracz J; Luczak M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299112
[TBL] [Abstract][Full Text] [Related]
10. Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial stiffness.
Yong K; Ooi EM; Dogra G; Mannion M; Boudville N; Chan D; Lim EM; Lim WH
Cytokine; 2013 Oct; 64(1):39-42. PubMed ID: 23778029
[TBL] [Abstract][Full Text] [Related]
11. Hypomagnesemia and atherogenic dyslipidemia in chronic kidney disease: surrogate markers for increased cardiovascular risk.
Dey R; Rajappa M; Parameswaran S; Revathy G
Clin Exp Nephrol; 2015 Dec; 19(6):1054-61. PubMed ID: 25697595
[TBL] [Abstract][Full Text] [Related]
12. Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease.
Valdivielso JM; Coll B; Martín-Ventura JL; Moreno JA; Egido J; Fernández E; Blanco-Colio LM
J Nephrol; 2013; 26(6):1105-13. PubMed ID: 23475462
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE.
Raimondo F; Salemi C; Chinello C; Fumagalli D; Morosi L; Rocco F; Ferrero S; Perego R; Bianchi C; Sarto C; Pitto M; Brambilla P; Magni F
Mol Biosyst; 2012 Apr; 8(4):1040-51. PubMed ID: 22315040
[TBL] [Abstract][Full Text] [Related]
14. Global mapping of rat plasma proteins with a native proteomic approach using nondenaturing micro 2DE and quantitative LC-MS/MS.
Chen S; Wen M; Bu S; Wang A; Jin Y; Tan W
Electrophoresis; 2016 Dec; 37(23-24):3126-3136. PubMed ID: 27731504
[TBL] [Abstract][Full Text] [Related]
15. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.
Wojtaszek E; Oldakowska-Jedynak U; Kwiatkowska M; Glogowski T; Malyszko J
Oxid Med Cell Longev; 2021; 2021():6651367. PubMed ID: 33628373
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Data-Independent Acquisition Mass Spectrometry Proteomics and Weighted Correlation Network Analysis of Plasma Samples for the Discovery of Chronic Kidney Disease-Specific Atherosclerosis Risk Factors.
Dai D; Cheng Z; Feng S; Zhu Z; Yu J; Zhang W; Lu H; Zhang R; Zhu J
DNA Cell Biol; 2022 Nov; 41(11):966-980. PubMed ID: 36255451
[TBL] [Abstract][Full Text] [Related]
17. Native protein mapping and visualization of protein interactions in the area of human plasma high-density lipoprotein by combining nondenaturing micro 2DE and quantitative LC-MS/MS.
Jin Y; Bu S; Zhang J; Yuan Q; Manabe T; Tan W
Electrophoresis; 2014 Jul; 35(14):2055-64. PubMed ID: 24668886
[TBL] [Abstract][Full Text] [Related]
18. Rat plasma proteomics: effects of abundant protein depletion on proteomic analysis.
Linke T; Doraiswamy S; Harrison EH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):273-81. PubMed ID: 17188586
[TBL] [Abstract][Full Text] [Related]
19. Proteomic identification of plasma proteins as markers of growth promoter abuse in cattle.
Kinkead RA; Elliott CT; Cannizzo FT; Biolatti B; Mooney MH
Anal Bioanal Chem; 2015 Jun; 407(15):4495-507. PubMed ID: 25912459
[TBL] [Abstract][Full Text] [Related]
20. Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach.
Gajjala PR; Bruck H; Noels H; Heinze G; Ceccarelli F; Kribben A; Saez-Rodriguez J; Marx N; Zidek W; Jankowski J; Jankowski V
J Mol Med (Berl); 2019 Oct; 97(10):1451-1463. PubMed ID: 31385015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
